Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

University of California, San Francisco3,000 enrolled

Overview

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Hidradenitis Suppurativa

Eligibility

Sex: ALLMin age: 10 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male or female ≥ 10 years of age 2. Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS 3. Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study. Exclusion Criteria: 1\. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.

Locations (1)

University of California San Francisco

San Francisco, California, United States

Outcomes

Primary Outcomes

Primary Objective

The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.

Time frame: 2019-2035

Secondary Outcomes

Secondary Objective

Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy.